Empagliflozin,dapagliflozin,Sotagliflozin
boehringer ingelheim,eli lilly,astrazeneca,Lexicon Pharmaceuticals
['heart failure']
sglt2 inhibitors have a role in modifying risk of kidney disease progression &amp; aki in those w/ type 2 dm at cv risk, and also in those w/ ckd or heart failure irrespective of diabetes status, primary kidney disease, or kidney function ca. 2022 #aha22 #kidneywk #nephpearls 
Chicago Sports Fan... Nephrologist by day. My tweets are not medical advice. The views expressed here are my own and not those of my employer.